Zobrazeno 1 - 10
of 98
pro vyhledávání: '"M. Castresana"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Brain Stimulation, Vol 12, Iss 2, Pp 582-(2019)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d7fde1a3b0476368a3b4408f40b268e
http://www.sciencedirect.com/science/article/pii/S1935861X18313512
http://www.sciencedirect.com/science/article/pii/S1935861X18313512
Autor:
E Lacalle-Fabo, Marta Gutiérrez-Valencia, M Castresana-Elizondo, MP Monforte-Gasque, A Galbete, Nicolás Martínez-Velilla
Publikováno v:
Section 5: Patient Safety and Quality Assurance.
Background Anticholinergic burden of medications has been linked to a number of adverse outcomes in older adults. It has demonstrated a negative impact on health outcomes such as cognitive impairment or falls, and many studies have recently investiga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::379c4d33be35992805059106aaed6afb
https://doi.org/10.1136/ejhpharm-2019-eahpconf.565
https://doi.org/10.1136/ejhpharm-2019-eahpconf.565
Autor:
A Gascón Villacampa, B Tirapu Nicolás, M Pio Asin, N Alzueta Isturiz, M Luri Fernandez de Manzanos, M Marín Marín, M Castresana Elizondo
Publikováno v:
Section 2: Selection, Procurement and Distribution.
Background Problems caused by medicines shortages are serious, threaten patient care in hospitals and require urgent action. Purpose To evaluate the economic impact of drugs’ shortages and analyse the consequences that it entailed in hospital pharm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c81a6f8ac81387ff4f4606379ed36a3
https://doi.org/10.1136/ejhpharm-2019-eahpconf.74
https://doi.org/10.1136/ejhpharm-2019-eahpconf.74
Autor:
Nicolás Martínez-Velilla, E Lacalle-Fabo, Marta Gutiérrez-Valencia, M Castresana-Elizondo, J Alonso-Renedo, MP Monforte-Gasque
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background Treatment adherence is a very important issue in ensuring the correct effectiveness of treatments, and it is often compromised in older patients. To assess and improve patients’ treatment adherence is an important role of clinical pharma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d63dd852dad65f3a67bac66791bac94
https://doi.org/10.1136/ejhpharm-2019-eahpconf.375
https://doi.org/10.1136/ejhpharm-2019-eahpconf.375
Autor:
M Castresana-Elizondo, E Lacalle-Fabo, J Alonso-Renedo, MP Monforte-Gasque, Marta Gutiérrez-Valencia, Nicolás Martínez-Velilla
Publikováno v:
Section 5: Patient Safety and Quality Assurance.
Background Older adults are at high risk of adverse drugs events (ADEs) and these are often a cause of hospitalisation in this population. Factors associated with drug-related hospital admissions are not well known. Purpose To estimate the prevalence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::619e5e6b79e258fe7f3d17f33d93d8e8
https://doi.org/10.1136/ejhpharm-2019-eahpconf.566
https://doi.org/10.1136/ejhpharm-2019-eahpconf.566
Autor:
E Lacalle Fabo, J Alfaro Basarte, M Castresana Elizondo, E. Pellejero Hernando, MP Monforte Gasque, R Astiz Lizarraga, M. Gutiérrez Valencia, M Elviro Llorens, I Hernández García
Publikováno v:
Clinical pharmacy.
Background Panitumumab is a fully human monoclonal antibody Ig G2 whose target is the epidermal growth factor receptor (EGFR). It is indicated as monotherapy to treat patients with metastatic colorectal cancer (mCRC) that show EGFR with wild-type KRA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5168d2844133c99f6dc217304e264974
https://doi.org/10.1136/ejhpharm-2017-000640.220
https://doi.org/10.1136/ejhpharm-2017-000640.220
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J. M. Castresana, C. Bao
Publikováno v:
SPIE Proceedings.
The conventional metamaterials require both negative permittivity (e) and negative permeability (μ), to achieve negative refraction. Chiral metamaterial is a new class of metamaterials offering a simpler route to negative refraction. In this paper,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::228859ad8cc5a4f5a2d0782f59b4b352
https://doi.org/10.1117/12.847132
https://doi.org/10.1117/12.847132